Biologic Drugs

Nov 02, 2011
Pharmaceutical Technology
Biosimilar manufacturers need better expression systems and analytical tools to compete.
Nov 02, 2011
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Small drug companies with hopes of achieving $1 billion in sales can pursue various strategies.
Oct 06, 2011
ePT--the Electronic Newsletter of Pharmaceutical Technology
By Pharmaceutical Technology Editors
EMA released two concept papers for consultation that address the need to revise existing guidelines on biosimilar medicines and influenza vaccines.
Oct 02, 2011
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Average deal size and amounts invested increased in the second quarter, but totals trail funding of last year.
Sep 21, 2011
Equipment and Processing Report
By Pharmaceutical Technology Editors
In a 2004 guidance, FDA says that the "use of redundant sterilizing filters should be considered in many cases." But not all manufacturers agree on what redundant filtration is.
Sep 01, 2011
Pharmaceutical Technology Europe
By Pharmaceutical Technology Editors
Recently, there have been many innovations in the latest techniques and technologies in API purification. In particular, the trend to single-use systems has had a significant impact on processes.
Sep 01, 2011
Pharmaceutical Technology Europe
By Pharmaceutical Technology Editors
Highly potent APIs (HPAPIs) represent a growing area of interest for the pharma industry. Mark Griffiths, CEO of Carbogen Amcis AG, explains why.
Sep 01, 2011
Pharmaceutical Technology Europe
By Pharmaceutical Technology Editors
Elham Blouet from Roquette explains the importance of carbohydrates for injection and the challenges in this niche market.
Aug 11, 2011
ePT--the Electronic Newsletter of Pharmaceutical Technology
Since the passage of the BPCI Act in 2009, manufacturers have been waiting for guidance from FDA on what that approval process will look like.
Aug 02, 2011
Pharmaceutical Technology
By Pharmaceutical Technology Editors
A path to personalized medicines creates a new paradigm for development and manufacturing.
native1_300x100
lorem ipsum